Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. senior Avg
|
|
New words:
anesthesiologist, Apotex, Army, arthralgia, assay, ballot, begun, Bet, Blue, Byooviz, card, Celltrion, Chair, chargeback, Cibinqo, climate, Command, Commissioner, conventional, Corectim, council, COVID, CPPA, CPRA, CRISPR, CSU, dander, deadline, deceptive, deferral, DEI, delgocitinib, Delta, demographic, discarded, disclaimer, dominant, easily, ebb, facial, feasible, Fel, frequency, fulfil, fulfill, groove, Helsinki, HLA, HMO, Humana, ID, inferior, insomnia, intracellular, Jersey, JP, judge, LCC, leukocyte, markedly, melanoma, MHRA, misled, month, mortality, Nykode, OECD, Omicron, onboarded, organoid, OUII, overexpressing, overlap, passion, PGR, PHI, prayer, PREA, proteomic, PTE, purportedly, quantity, qui, quickly, reauthorized, redesign, registry, reintegration, resubmission, RICO, Rinvoq, Ronapreve, ROW, safeguard, safeguarding, safer, satisfaction, Shield, struck, subdivided, subsection, succeed, Susvimo, Switzerland, synthetic, tam, Tezspire, Tobacco, toothache, transmit, Ultragenyx, unfair, unsealed, unsettled, uptake, Vabysmo, voice, Voluntarily, weakened, WTO, young
Removed:
achieved, Activin, adjudicate, adolescent, advocacy, Allergan, amounted, answer, appointment, ASC, ASU, canakinumab, cast, Chairman, Chancery, Chimie, classification, Codification, commencing, compensatory, construed, contemporaneously, de, deduction, destroy, Deutschland, disposal, dispose, disputed, dissolution, emerged, enactment, enforced, expert, foot, FOP, front, giant, grande, ground, Groupe, Hague, headcount, hip, identifiable, Industrie, inequitable, insufficiency, introduce, IPHC, isogenic, Kymab, liquidation, MA, nonemployee, nonqualified, older, orally, owner, personally, polymyalgia, programmed, prohibiting, proportionally, provisional, qualifying, reassessed, reconciled, reopen, reopened, retrospective, rheumatica, RSV, rulemaking, satisfying, sJIA, smaller, spend, sponsored, staying, suptavumab, Tribunal, unaudited, unmarketable, unregistered, winding, Winthrop, withdrawing
Filing tables
Filing exhibits
- 10-K Annual report
- 10.14.4 Fourth Amendment to License and Collab Agreement - Sanofi
- 10.18.1 Amendment 01 to Credit Agreement - Jpmorgan Chase Bank Na and Lenders
- 10.20.1 First Amendment to Io License and Collab Agreement - Sanofi
- 10.25.1 First Amendment to Participation Agreement
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification of CEO Pursuant to Rule 13A-14(A)
- 31.2 Certification of CFO Pursuant to Rule 13A-14(A)
- 32 Certification of CEO and CFO Pursuant to 18 U.s.c. Section 1350
- Download Excel data file
- View Excel data file
Related press release
Associated REGN transcripts
REGN similar filings
Filing view
External links